Full Title: Inhalable Drug Delivery: Industry Holds its Breath in Anticipation of Systemic Success
FREE BONUS REPORT(S): When you buy below report, you may pick 1 additional cancer report for free from this list
(Value: 2,468 USD)
Introduction Currently driven by the needs of the expanding respiratory market, the inhalable drug delivery sector has also been invigorated by the promise of growth through the systemic delivery of drugs via the lungs as the first inhalable insulin nears the market. But whether the technology can deliver on its promise has yet to be proven. Scope - Presents historical and forecast sales (2001-2010) of the inhalable products that will drive demand for future inhalable drug delivery technology
- Profiles the seven leading inhalable technology providers, benchmarking their strategic outlook, financial position, technology platform and pipeline
- Evaluates the growth potential of this sector of the drug delivery market and the expected impact of systemic inhalable drugs reaching the market
- Examines the pulmonary and systemic markets, detailing the key issues impacting the present and future, for each of these contrasting markets
Highlights Although currently driven by the respiratory market, demand for inhalable drug delivery technology looks set to increase rapidly in the longer term if systemic inhalable therapies can achieve their full potential Generic drug manufacturers, such as Ivax, are increasingly developing or acquiring the expertise to enhance generic pulmonary treatments by applying proprietary technology. This represents a real threat to the current pulmonary market value as the result would increase competition from cheaper branded "super-generic" products Inhalable devices provide a more patient-acceptable delivery for protein therapeutics. However, the late stage inhalable insulin devices are bulky with usability issues which may confuse and discourage the patient population and act as a barrier to uptake. It is crucial that technological improvements are made in order to ensure long term growth Reasons to Purchase - Understand the key drivers and resistors of growth within this area of drug delivery
- Benchmark your position within the inhalable drug delivery market and identify the optimum strategy for future growth
- Evaluate the comparative opportunities offered by the different indications being targeted by inhalable therapies
Pages: 124 Table of Contents Download TOC in PDF
|
